Investment
Features
FeesSafety
Academy
More
Pluang+

Banco Macro SA to report Q2 earnings with mixed analyst views and recent stock drop

Company Fundamentals
19 Aug 2026
Alex Lavoie
View Source
Neutral
pluang ai news

Banco Macro SA is set to release its Q2 2026 earnings, with analysts expecting an EPS of $1.71 and revenues near $946 million. The stock has fallen 3.5% recently, contributing to a 12.3% decline year-to-date amid high volatility expectations from options traders. While Zacks rates the stock as a buy, GuruFocus considers it significantly overvalued compared to its estimated intrinsic value. The bank shows a moderate P/E ratio of 19.56 and low debt levels, indicating manageable financial risk as investors await the earnings report.

More News

Viking Holdings posts strong Q2 with 16.5% revenue rise and fleet expansion despite operational risks.

Viking Holdings posts strong Q2 with 16.5% revenue rise and fleet expansion despite operational risks.

Viking Holdings reported better-than-expected Q2 earnings with revenue up 16.5% to $2.19 billion and EPS of $1.31, beating estimates. The growth was driven by adding seven river and two ocean vessels, increasing passenger cruise days by 10.9%. Howeve...

Company Fundamentals
Bullish
47 minutes ago
Belden's Q2 revenue hits record $750M, stock seen rising 31.7% on AI growth and strong outlook.

Belden's Q2 revenue hits record $750M, stock seen rising 31.7% on AI growth and strong outlook.

Belden, Inc. reported a record second-quarter revenue of $750.20 million, driven by its role as a key supplier in AI infrastructure. Analysts raised the price target to $170, suggesting a potential 31.68% upside from the current price of around $129....

Analyst Insights
Bullish
1 hour ago
Director Carande buys 2,101 shares of United Community Banks, signaling confidence.

Director Carande buys 2,101 shares of United Community Banks, signaling confidence.

Director Carande has purchased 2,101 shares of United Community Banks. This insider buying may indicate confidence in the company's future prospects. Investors often view such transactions as a positive signal, potentially influencing market sentimen...

Market News
Neutral
1 hour ago
Bio-Techne Q4 revenue beats estimates; Merck KGaA acquisition keeps stock near $73 offer price.

Bio-Techne Q4 revenue beats estimates; Merck KGaA acquisition keeps stock near $73 offer price.

Bio-Techne reported Q4 revenues of $321.2 million, slightly surpassing estimates, but its adjusted EPS fell 1.9% year-over-year to $0.52, showing mixed financial results. The company's stock remains close to Merck KGaA's $73 per share acquisition off...

Company Fundamentals
Neutral
1 hour ago
Estée Lauder beats earnings estimates with strong sales growth and optimistic outlook

Estée Lauder beats earnings estimates with strong sales growth and optimistic outlook

Estée Lauder reported quarterly earnings per share of $0.39, surpassing analyst estimates of $0.32, and revenue of $3.62 billion, exceeding expectations. The company showed 5% organic sales growth for the fourth consecutive quarter and raised its ful...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App